Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain

European Journal of Pharmacology

Volumn 429, Issue 1-3, 2001, Pages 177-193

  Holzer, Peter ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Capsaicin receptor; Enteric nervous system; Functional bowel disorder; Neuropeptide receptor; Purinoceptor; Sensory neuron; Visceral hyperalgesia; Visceral pain

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ALOSETRON; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRADYKININ RECEPTOR; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CANNABINOID RECEPTOR; CAPSAICIN; CHOLECYSTOKININ RECEPTOR; CISAPRIDE; CLONIDINE; GLUTAMATE RECEPTOR; ION CHANNEL; KAPPA OPIATE RECEPTOR AGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE RECEPTOR; PROSTAGLANDIN RECEPTOR; PROTEIN KINASE C; PRUCALOPRIDE; PURINE P2X RECEPTOR; PURINE RECEPTOR; RECEPTOR SUBTYPE; SDZ 249 665; SEROTONIN; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SODIUM CHANNEL; SOMATOSTATIN RECEPTOR; TACHYKININ RECEPTOR; TEGASEROD; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR;

ABDOMINAL DISEASE; ANTINOCICEPTION; DRUG EFFECT; DRUG SELECTIVITY; DRUG TARGETING; DYSPEPSIA; HUMAN; HYPERALGESIA; INTESTINE INNERVATION; IRRITABLE COLON; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SENSORY NERVE; SIGNAL TRANSDUCTION; VISCERAL PAIN;

ANIMALS; CHEST PAIN; COLONIC DISEASES, FUNCTIONAL; DRUG DELIVERY SYSTEMS; DYSPEPSIA; GASTROINTESTINAL DISEASES; HUMANS; NEURONS, AFFERENT;

EID: 0035840835     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01319-X     Document Type: Review

References (216)

1. Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons
2. μ-Opioid receptors are present in vagal afferents and their dendritic targets in the medial nucleus tractus solitarius
3. Acid-sensing pathways of rat duodenum
4. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways
5. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development
6. Effect of opioid active therapeutics on the ascending reflex pathway in the rat ileum
7. 3 receptor antagonists and antiemesis
8. A receptors on rat vagal afferent neurones
9. The human intestinal microflora: Physiology and pathophysiology
10. + channels in pain pathways
11. A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome
12. Connections between P2 purinoceptors and capsaicin-sensitive afferents in the intestine and other tissues
13. Functional and chemical anatomy of the afferent vagal system
14. Capsaicin-resistant vagal afferent fibers in the rat gastrointestinal tract: Anatomical identification and functional integrity
15. Vagal-enteric interface: Vagal activation-induced expression of c-fos and p-CREB in neurons of the upper gastrointestinal tract and pancreas
16. The terminals of myenteric intrinsic primary afferent neurons of the guinea-pig ileum are excited by 5-hydroxytryptamine acting at 5-hydroxytryptamine-3 receptors
17. 4 receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans
18. Differential effects of capsaicin on rat visceral sensory neurons
19. 2-adrenergic receptors in rat primary afferent neurones after peripheral nerve injury or inflammation
20. Acute effects of capsaicin on gastrointestinal vagal afferents
21. The role of EP receptors in hyperalgesia
22. Fedotozine, a κ-opioid agonist, prevents spinal and supra-spinal Fos expression induced by a noxious visceral stimulus in the rat
23. 4 agonist, prucalopride, in healthy humans
24. Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone
25. Gastrointestinal prokinetic benzamides: The pharmacology underlying stimulation of motility
26. Mediators and pharmacology of visceral sensitivity: From basic to clinical investigations
27. Purine-mediated signalling in pain and visceral perception
28. Control of pain initiation by endogenous cannabinoids
29. Management of the irritable bowel syndrome
30. Review article: Tegaserod
31. Imipramine in patients with chest pain despite normal coronary angiograms
32. Inflammation-induced changes in peripheral glutamate receptor populations
33. The capsaicin receptor: A heat-activated ion channel in the pain pathway
34. Impaired nociception and pain sensation in mice lacking the capsaicin receptor
35. Sensory innervation of the viscera: Peripheral basis of visceral pain
36. Visceral pain
37. A P2X purinoceptor expressed by a subset of sensory neurons
38. A sensory neuron-specific, proton-gated ion channel
39. Octreotide reduces perception of rectal electrical stimulation by spinal afferent pathway inhibition
40. 3-deficient mice
41. Effect of the κ agonist fedotozine on perception of gastric distension in healthy humans
42. The immunomodulation of enteric neuromuscular function: Implications for motility and inflammatory disorders
43. Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2
44. Opioid antinociception in a rat model of visceral pain: Systemic versus local drug administration
45. Cytokines and sickness behavior
46. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia
47. The κ agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome
48. Functional gut disorders: From motility to sensitivity disorders. A review of current and investigational drugs for their management
49. Potential of substance P antagonists as antiemetics
50. Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat formalin model
51. P2 receptors meet the immune system
52. Opioid-receptor-mediated excitation of rat mesenteric afferent fibres supplying the rat jejunum
53. Activation of vagal afferents after intravenous injection of interleukin-1β: Role of endogenous prostaglandins
54. 2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade
55. Involvement of capsaicin-sensitive afferent nerves in the intestinal motor alterations induced by intestinal anaphylaxis in rats
56. Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia
57. Inhibition of cisplatin-induced emesis in ferrets by the non-NMDA receptor antagonists NBQX and CNQX
58. Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions
59. Glutamate in the nucleus of the solitary tract activates both ionotropic and metabotropic glutamate receptors
60. Involvement of prostaglandins and CGRP-dependent sensory afferents in peritoneal irritation-induced visceral pain
61. In vivo antinociceptive activity of anti-rat mGluR1 and mGluR5 antibodies in rats
62. Responses of afferent neurons to the contents of the digestive tract, and their relation to endocrine and immune responses
63. Intrinsic primary afferent neurons of the intestine
64. Transmitters involved in antinociception in the spinal cord
65. Multiple mechanisms of fast excitatory synaptic transmission in the enteric nervous system
66. Involvement of tachykinin receptors in sensitisation to cow's milk proteins in guinea pigs
67. Pathobiology of visceral pain: Molecular mechanisms and therapeutic implications: IV. Visceral afferent contributions to the pathobiology of visceral pain
68. Effect of capsaicin-containing red pepper sauce suspension on upper gastrointestinal motility in healthy volunteers
69. 2-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds?
70. Characterization of the peptidergic afferent innervation of the stomach in the rat, mouse, and guinea-pig
71. Intestinal type 2 proteinase-activated receptors: Expression in opioid-sensitive secretomotor neural circuits that mediate epithelial ion transport
72. Sensory afferents from the gastrointestinal tract
73. Immunocytochemical localization of the vanilloid receptor 1 (VR1): Relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites
74. Activation of visceral afferents by bradykinin and ischemia: Independent roles of PKC and prostaglandins
75. The role of psychological and biological factors in postinfective gut dysfunction
76. Intraluminal capsaicin does not affect fluid and electrolyte absorption in the human jejunum but does cause pain
77. Prostaglandin EP receptor subtypes have distinct effects on jejunal afferent sensitivity in the rat
78. Differential sensitivity of antinociceptive assays to the bradykinin antagonist Hoe 140
79. Different receptors mediating the inhibitory action of exogenous ATP and endogenously released purines on guinea-pig intestinal peristalsis
80. Cannabinoid inhibition of guinea-pig intestinal peristalsis via inhibition of excitatory and activation of inhibitory neural pathways
81. Cannabinoid receptors undergo axonal flow in sensory nerves
82. Capsaicin: Cellular targets, mechanisms of action, and selectivity for thin sensory neurons
83. Neural emergency system in the stomach
84. Implications of tachykinins and calcitonin gene-related peptide in inflammatory bowel disease
85. Neural injury, repair, and adaptation in the GI tract: II. The elusive action of capsaicin on the vagus nerve
86. Inflammation and gut hypersensitivity: Peripheral mechanisms
87. Sensory neurons in the intestine
88. Tachykinins in the gut: Part I. Expression, release and motor function
89. Tachykinins in the gut: Part II. Roles in neural excitation, secretion and inflammation
90. Sensory neurons signal for an increase in rat gastric mucosal blood flow in the face of pending acid injury
91. Essential role of vagal afferents in the central signalling of a gastric mucosal acid insult
92. Traction on the mesentery as a model of visceral nociception
93. 1-antagonist RP 67580 in inhibiting chemonociception
94. Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances
95. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats
96. 2 receptor antagonists upon viscero-visceral hyper-reflexia in a rat model of visceral hyperalgesia
97. 2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain
98. The capsaicin analogue SDZ 249-665 attenuates the hyperreflexia and referred hyperalgesia associated with inflammation of the rat urinary bladder
99. Expression of μ-, δ-, and κ-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation
100. 2 receptors in the medullary transmission of vagal afferent input from the acid-threatened rat stomach
101. Acid potentiation of the capsaicin receptor determined by a key extracellular site
102. κ-Opioid receptor agonists modulate visceral nociception at a novel, peripheral site of action
103. Tachykininergic mediation of viscerosensitive responses to acute inflammation in rats: Role of CGRP
104. Influence of bradykinin in gastrointestinal disorders and visceral pain induced by acute or chronic inflammation in rats
105. Role of neurokinin 3 receptors on responses to colorectal distention in the rat: Electrophysiological and behavioral studies
106. Epithelial cells as sensors for microbial infection
107. Glutamate and aspartate immunoreactivity in dorsal root ganglion cells supplying visceral and somatic targets and evidence for peripheral axonal transport
108. Distribution of AMPA receptor subunits GluR1-4 in the dorsal vagal complex of the rat: A light and electron microscope immunocytochemical study
109. Excitatory effect of P2X receptor activation on mesenteric afferent nerves in the anaesthetised rat
110. Receptors and transmission in the brain-gut axis: Potential for novel therapies. I. Receptors on visceral afferents
111. 3 receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat
112. The effect of fentanyl, DNQX and MK-801 on dorsal horn neurones responsive to colorectal distension in the anaesthetized rat
113. Distinct mechanism for antidepressant activity by blockade of central substance P receptors
114. 1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system
115. 2-induced sensitization of polymodal receptors in response to bradykinin and heat
116. A capsaicin-receptor antagonist, capsazepine, reduces inflammation-induced hyperalgesic responses in the rat: Evidence for an endogenous capsaicin-like substance
117. Approaches to nonsteroidal anti-inflammatory drug use in the high risk patient
118. 1 receptor gene
119. Fedotozine blocks hypersensitive visceral pain in conscious rats: Action at peripheral κ-opioid receptors
120. Neurotrophins and the specification of neuronal phenotype
121. 3 receptor subunits can account for ATP-gated currents in sensory neurons
122. B agonist baclofen in normal subjects
123. NMDA-receptor regulation of substance P release from primary afferent nociceptors
124. Substance P post-synaptically potentiates glutamate-induced currents in dorsal vagal neurons
125. Duodenal acid-induced gastric relaxation is mediated by multiple pathways
126. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves
127. Tachykinins as peripheral modulators of primary afferent nerves and visceral sensitivity
128. The role of the vagus nerve in cytokine-to-brain communication
129. A, receptor activation inhibits electrically evoked substance P-like immunoreactivity release from the rat spinal cord in vitro
130. NMDA receptor activation modulates evoked release of substance P from rat spinal cord
131. 2 adrenergic modulation of colonic and rectal motor and sensory function
132. B receptors
133. The role of prostaglandins in the bradykinin-induced activation of serosal afferents of the rat jejunum in vitro
134. Gut feelings: What turns them on?
135. Basic and clinical aspects of visceral hyperalgesia
136. Central and peripheral expression of neurokinin-1 and neurokinin-3 receptor and substance P-encoding messenger RNAs: Peripheral regulation during formalin-induced inflammation and lack of neurokinin receptor expression in primary afferent sensory neurons
137. 2 receptors
138. Effects of tachykinin receptor antagonists on the rat jejunal distension pain response
139. 2 receptors and mast cells in post intestinal infection-induced hypersensitivity to distension
140. The effect of octreotide on human gastric compliance and sensory perception
141. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human
142. Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy
143. Vagal afferent signaling of a gastric mucosal acid insult to medullary, pontine, thalamic, hypothalamic and limbic, but not cortical, nuclei of the rat brain
144. The induction of pain: An integrative review
145. Double in situ hybridization study on coexistence of μ-, δ- and κ-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia
146. 3 receptor in the rat nervous system
147. Pharmacology of cloned P2X receptors
148. Regulation of expression of the sensory neuron-specific sodium channel SNS in inflammatory and neuropathic pain
149. 2-Adrenergic receptors in human dorsal root ganglia
150. Inhibitory effects of clonidine and tizanidine on release of substance P from slices of rat spinal cord and antagonism by α-adrenergic receptor antagonists
151. Increased mast cells in the irritable bowel syndrome
152. Differential effects of μ-, δ-, and κ-opioid receptor agonists on mechanosensitive gastric vagal afferent fibers in the rat
153. B receptors inhibit mechanosensitivity of primary afferent endings
154. P2X purinoceptor-induced sensitization of ferret vagal mechanoreceptors in oesophageal inflammation
155. B receptors on vagal afferent pathways: Peripheral and central inhibition
156. Differences in expression of oligosaccharides, neuropeptides, carbonic anhydrase and neurofilament in rat primary afferent neurons retrogradely labelled via skin, muscle or visceral nerves
157. 2 receptors
158. Role of bradykinin in the hyperaemia following acid challenge of the rat gastric mucosa
159. Tension and stretch receptors in gastrointestinal smooth muscle: Re-evaluating vagal mechanoreceptor electrophysiology
160. The endocannabinoid system as a target for therapeutic drugs
161. Calcitonin gene-related peptide in viscerosensitive response to colorectal distension in rats
162. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain
163. Induction of vanilloid receptor channel activity by protein kinase C
164. Vagal afferent modulation of nociception
165. Nutrient tasting and signaling mechanisms in the gut: I. Sensing of lipid by the intestinal mucosa
166. Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia
167. Tissue acidosis in nociception and pain
168. Peripheral and preemptive opioid antinociception in a mouse visceral pain model
169. Vagal afferent stimulation-produced effects on nociception in capsaicin-treated rats
170. A receptor activation
171. Responses to cholecystokinin octapeptide in patients with functional abdominal pain syndromes
172. The effects of capsaicin on reflux, gastric emptying and dyspepsia
173. 2+ currents in rat nodose ganglion neurons
174. Desipramine potentiates spinal antinociception by 5-hydroxytryptamine, morphine and adenosine
175. Immunohistochemical detection of glutamate in rat vagal sensory neurons
176. Gastric acid-evoked c-fos messenger RNA expression in rat brainstem is signaled by capsaicin-resistant vagal afferents
177. Gastrointestinal afferent fibers and sensation
178. Effects of κ opioids in the inflamed rat colon
179. The intestinal immune system
180. Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: Long-term results for the treatment of detrusor hyperreflexia
181. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome
182. Triggering of transient LES relaxations in ferrets: Role of sympathetic pathways and effects of baclofen
183. Enteric and visceral afferent CGRP neurons. Targets of innervation and differential expression patterns
184. Expression of cholecystokinin A receptors in neurons innervating the rat stomach and intestine
185. Effects of tricyclic antidepressants on mechanosensitive pelvic nerve afferent fibers innervating the rat colon
186. Capsaicin sensitivity and voltage-gated sodium currents in colon sensory neurons from rat dorsal root ganglia
187. Mechanosensitive potassium channels in rat colon sensory neurons
188. Vanilloid (capsaicin) receptors and mechanisms
189. New perspectives on enigmatic vanilloid receptors
190. Physiology of prevertebral ganglia
191. Effects of capsaicin on myenteric neurons of the guinea pig ileum
192. The role of capsaicin-sensitive sensory neurons in healing of HCl-induced gastric mucosal lesions in rats
193. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia
194. A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin
195. 2-adrenergic agents in humans
196. The cloned capsaicin receptor integrates multiple pain-producing stimuli
197. Differential c-fos expression in the nucleus of the solitary tract and spinal cord following noxious gastric distention in the rat
198. 2-Adrenoceptor-mediated inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices
199. Modulation of spinal excitability: Co-operation between neurokinin and excitatory amino acid neurotransmitters
200. In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue
201. Protease-activated receptors in inflammation, neuronal signaling and pain
202. Inhibition of spinal protein kinase C blocks substance P-mediated hyperalgesia
203. +-gated cation channels
204. mGlu5 receptors and nociceptive function. II. mGlu5 receptors functionally expressed on peripheral sensory neurons mediate inflammatory hyperalgesia
205. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
206. Modulation of peristalsis in the guinea-pig isolated small intestine by exogenous and endogenous opioids
207. Brain derived neurotrophic factor, but not nerve growth factor, regulates capsaicin sensitivity of rat vagal ganglion neurones
208. Fundamentals of neurogastroenterology
209. Neuronal plasticity: Increasing the gain in pain
210. GABAergic effects on nucleus tractus solitarius neurons receiving gastric vagal inputs
211. The NMDA receptor antagonist MK-801 attenuates c-fos expression in the lumbosacral spinal cord following repetitive noxious and non-noxious colorectal distention
212. Effect of brain stem NMDA-receptor blockade by MK-801 on behavioral and Fos responses to vagal satiety signals
213. Neurochemistry of the nodose ganglion
214. Enhanced phosphorylation of NMDA receptor 1 subunits in spinal cord dorsal horn and spinothalamic tract neurons after intradermal injection of capsaicin in rats
215. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide